Drug Shortage Report for PROSTIN E2 TABLETS
| Report ID | 246051 |
| Drug Identification Number | 00400688 |
| Brand name | PROSTIN E2 TABLETS |
| Common or Proper name | PROSTIN E2 TABLETS |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DINOPROSTONE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 10'S TABLETS |
| ATC code | G02AD |
| ATC description | UTEROTONICS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2024-12-19 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-10-09 | French | Compare |
| v6 | 2025-10-09 | English | Compare |
| v5 | 2025-08-07 | French | Compare |
| v4 | 2025-08-07 | English | Compare |
| v3 | 2024-12-20 | English | Compare |
| v2 | 2024-12-19 | French | Compare |
| v1 | 2024-12-19 | English | Compare |
Showing 1 to 7 of 7